Both in Pharmaceuticals
Dare Bioscience vs Cellectar Biosciences INC NEW
Over the past year DARE returned −69.4% and CLRB returned −69.5%; their daily moves had a correlation of 0.08.
DARE −69.4% CLRB −69.5%Growth of $1, one year, split-adjusted
| Metric | DARE | CLRB |
|---|---|---|
| Price | $0.6459 | $1.22 |
| Market cap | $12.7M | $11.5M |
| Today | −0.89% | +4.27% |
| 1 month | −12.8% | −41.2% |
| 6 months | −69.4% | −55.8% |
| Year to date | −66.5% | −58.6% |
| 1 year | −68.8% | −68.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | −70.6% | — |
| Net margin | −1590.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.3× | — |
| Net cash | $12.5M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 100.3% | 67.0% |
| Short % of float | 5.0% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).